30 Sept 2026, 09:16
Securities Administration—
LDXLUMOS DIAGNOSTICS HOLDINGS LIMITED
Announcement history available from 1 August 2025
Fromto
30 Sept 2026, 09:14
Securities Administration—
15 Sept 2026, 16:40
Substantial Holders—
15 Sept 2026, 12:38
Securities Administration—
15 Sept 2026, 12:37
Securities Administration—
15 Sept 2026, 09:26
Company UpdateMS
1 Sept 2026, 13:50
Securities Administration—
1 Sept 2026, 13:48
Securities Administration—
1 Sept 2026, 13:04
Director Interests—
26 Aug 2026, 10:06
Company Administration—
26 Aug 2026, 09:44
Financial ResultsMS
26 Aug 2026, 09:41
Financial Results—
26 Aug 2026, 09:22
Financial ResultsMS
7 Aug 2026, 11:02
Presentations—
4 Aug 2026, 09:04
Company UpdateMS
30 July 2026, 09:38
Company Update—
28 July 2026, 12:42
Director Interests—
28 July 2026, 09:40
Securities Administration—
28 July 2026, 09:37
Securities Administration—
27 July 2026, 12:01
Presentations—
27 July 2026, 09:55
Quarterly ReportsMS
21 July 2026, 12:08
Company UpdateMS
20 July 2026, 11:01
Periodic Reports—
20 July 2026, 10:50
Company Administration—
14 July 2026, 13:06
Securities Administration—
2 July 2026, 14:27
Capital Raising—
29 June 2026, 09:54
Periodic ReportsMS
25 June 2026, 11:48
Director Interests—
22 June 2026, 12:12
Securities Administration—
19 June 2026, 09:13
Director Interests—
11 June 2026, 09:58
Presentations—
5 June 2026, 14:51
Director Interests—
4 June 2026, 11:23
Presentations—
20 May 2026, 13:24
Securities Administration—
20 May 2026, 13:24
Securities Administration—
18 May 2026, 11:42
Company UpdateMS
18 May 2026, 09:49
Company UpdateMS
14 May 2026, 09:37
Company UpdateMS
7 May 2026, 14:02
Periodic Reports—
1 May 2026, 11:16
Director Interests—
1 May 2026, 11:16
Director Interests—
1 May 2026, 11:11
Securities Administration—
1 May 2026, 11:10
Securities Administration—
1 May 2026, 11:08
Securities Administration—
1 May 2026, 11:04
Capital Raising—
30 Apr 2026, 16:23
Director Interests—
21 Apr 2026, 10:32
Quarterly Reports—
20 Apr 2026, 09:49
Quarterly ReportsMS
16 Apr 2026, 09:33
Securities Administration—
15 Apr 2026, 16:26
Capital Raising—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 09:16 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 30 Sept 2026, 09:14 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 15 Sept 2026, 16:40 | Change in substantial holding from RYD | Substantial Holders | — | 02002 | |
| 15 Sept 2026, 12:38 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 15 Sept 2026, 12:37 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 15 Sept 2026, 09:26 | FebriDx Commercial Traction Continues Across US Accounts | Company Update | MS | 11001 | |
| 1 Sept 2026, 13:50 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 1 Sept 2026, 13:48 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 1 Sept 2026, 13:04 | Change of Director's Interest Notice - DW | Director Interests | — | 02009 | |
| 26 Aug 2026, 10:06 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 26 Aug 2026, 09:44 | FY26 Full Year Results Announcement | Financial Results | MS | 03003, 03014 | |
| 26 Aug 2026, 09:41 | FY26 Annual Report | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 26 Aug 2026, 09:22 | FY26 Appendix 4E | Financial Results | MS | 03003 | |
| 7 Aug 2026, 11:02 | Lumos to Present at 20th Bioshares Biotech Summit | Presentations | — | 03026 | |
| 4 Aug 2026, 09:04 | Lumos Receives FebriDx Order from PHASE Scientific | Company Update | MS | 11001 | |
| 30 July 2026, 09:38 | Lumos Secures Distribution for FebriDx in Romania | Company Update | — | 11001 | |
| 28 July 2026, 12:42 | Change of Director's Interest Notice - DW | Director Interests | — | 02009 | |
| 28 July 2026, 09:40 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 28 July 2026, 09:37 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 27 July 2026, 12:01 | Investor Presentation | Presentations | — | 03026, 14014 | |
| 27 July 2026, 09:55 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 14014, 19004, 19009 | |
| 21 July 2026, 12:08 | FebriDx Commercial Traction Across Priority US Accounts | Company Update | MS | 11001 | |
| 20 July 2026, 11:01 | Q4 FY26 Results Release Date and Webinar Invitation | Periodic Reports | — | 03027 | |
| 20 July 2026, 10:50 | Investor Information Sessions | Company Administration | — | 12008 | |
| 14 July 2026, 13:06 | Notification of cessation of securities - LDX | Securities Administration | — | 06027 | |
| 2 July 2026, 14:27 | Closure of A$5M Loan Facility with Major Shareholders | Capital Raising | — | 03022 | |
| 29 June 2026, 09:54 | Lumos Receives Research & Development Tax Rebate | Periodic Reports | MS | 03014 | |
| 25 June 2026, 11:48 | Change of Director's Interest Notice - SL | Director Interests | — | 02009 | |
| 22 June 2026, 12:12 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 19 June 2026, 09:13 | Change of Director's Interest Notice - CR | Director Interests | — | 02009 | |
| 11 June 2026, 09:58 | Investor Presentation - FebriDx US Commercial Update | Presentations | — | 03026 | |
| 5 June 2026, 14:51 | Change of Director's Interest Notice - DW | Director Interests | — | 02009 | |
| 4 June 2026, 11:23 | FebriDx US Commercial Update Webinar Invitation | Presentations | — | 14014 | |
| 20 May 2026, 13:24 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 20 May 2026, 13:24 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 18 May 2026, 11:42 | FebriDx U.S. Rollout and Reimbursement Update - Amended | Company Update | MS | 11001 | |
| 18 May 2026, 09:49 | FebriDx U.S. Rollout and Reimbursement Update | Company Update | MS | 11001 | |
| 14 May 2026, 09:37 | FebriDx Paediatric Study Enrolment Milestone Achieved | Company Update | MS | 11001 | |
| 7 May 2026, 14:02 | Lumos receives US$0.5m CLIA waiver milestone payment | Periodic Reports | — | 03014 | |
| 1 May 2026, 11:16 | Change of Director's Interest Notice - CR | Director Interests | — | 02009 | |
| 1 May 2026, 11:16 | Change of Director's Interest Notice - SL | Director Interests | — | 02009 | |
| 1 May 2026, 11:11 | Notification regarding unquoted securities - LDX | Securities Administration | — | 06021 | |
| 1 May 2026, 11:10 | Notification regarding unquoted securities - LDX | Securities Administration | — | 06021 | |
| 1 May 2026, 11:08 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 1 May 2026, 11:04 | Results of Share Purchase Plan | Capital Raising | — | 06017 | |
| 30 Apr 2026, 16:23 | Change of Director's Interest Notice - SL | Director Interests | — | 02009 | |
| 21 Apr 2026, 10:32 | Q3 FY26 Results Investor Presentation | Quarterly Reports | — | 03026, 19003 | |
| 20 Apr 2026, 09:49 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 16 Apr 2026, 09:33 | Notification of cessation of securities - LDX | Securities Administration | — | 06027 | |
| 15 Apr 2026, 16:26 | Lumos Q3 FY26 Results Webinar Invitation | Capital Raising | — | 03027, 06017, 14014 |
1–50 of 129
1 / 3